Point72 Middle East FZE »

Editas Medicine shares owned by Point72 Middle East FZE

Quarter-by-quarter ownership of Editas Medicine (EDIT) shares owned by Point72 Middle East FZE from 13F filings

Historical chart of Point72 Middle East FZE investment in Editas Medicine

Tip: Access up to 7 years of quarterly data

All positions including Editas Medicine held by Point72 Middle East FZE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Editas Medicine by Point72 Middle East FZE

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2M 119k 10.13
2023-09-30 $126k 16k 7.80
2023-06-30 $399k 49k 8.23
2023-03-31 $180k 25k 7.25

More positions owned by Point72 Middle East FZE

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
General Motors Company (GM)
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Caterpillar Call Option (CAT)
UnitedHealth (UNH)
Amazon (AMZN)
Jd.com Spon Adr Cl A (JD)
Lauder Estee Cos Cl A Call Option (EL)
Target Corporation Call Option (TGT)
At&t (T)
Analog Devices Call Option (ADI)
Synopsys (SNPS)

View all positions for Point72 Middle East FZE

Top funds holding Editas Medicine

Vanguard Group
Dimensional Fund Advisors
Millennium Management
Two Sigma Investments
D. E. Shaw & Co
Citadel Advisors
Two Sigma Advisers
Marshall Wace
Jpmorgan Chase & Co
Credit Suisse
Charles Schwab Investment Management
Squarepoint Ops
Point72 Asset Management
Voloridge Investment Management
Goldman Sachs Group

View all funds holding Editas Medicine